Facebook Linkedin Twitter
Inside Precision Medicine “Good” Bacteria Added to Gut Microbiome Can Combat Food Allergies

T-cells

Johnson & Johnson’s Janssen Research & Development will use BiomX's XMarker platform to discover microbiome-based biomarkers for inflammatory bowel disease (IBD)
Molecular Dx

“Good” Bacteria Added to Gut Microbiome Can Combat Food Allergies

0
IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System
Molecular Dx

IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System

Alex Philippidis
0
Mission Bio said today it has completed a $30 million Series B financing
Molecular Dx

With $30M Financing, Mission Bio Eyes Platform Development, Expansion into Gene Editing

0
Immune checkpoint protein molecule, illustration
News & Features

Checkpoint Inhibitor Generated by Synthetic DNA in Vivo

0
Nobel Peace Prize Ceremony 2008
News & Features

Allison, Honjo Share Nobel Prize for Immunotherapy Breakthroughs

0
T-lymphocytes attacking cancer cell
News & Features

Exosomes from Cancer Cells Could Predict Immunotherapy Responses

0
“Father of Gene Therapy” to be Released from Prison Next Month
News & Features

“Father of Gene Therapy” to be Released from Prison Next Month

0
The FDA’s embrace of precision oncology
News & Features

ASCO Care Advances Report Highlights CAR-T Approvals, Other Clinical Progress Against Cancer

0
Source: Meletios Verras/Getty Images
News & Features

CRISPR/Cas9 Can Create Killer T Cells Highly Sensitive to Cancer Cell Antigens

0
1...192021Page 21 of 21

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine